Research
Abstract Tendon-bone insertion injuries such as rotator cuff and anterior cruciate ligament injuries are currently highly common and severe. The key method of treating this kind of injury is the reconstruction operation. The success of this reconstructive process depends on the ability of the graft to incorporate into the bone. Recently, there has been substantial…
Read More ABSTRACT Despite relatively good results of current symptomatictreatments for rotator cuff disease, there has been an unmetneed for fundamental treatments to halt or reverse the progressof disease. The purpose of this study was to assess the safety andefficacy of intratendinous injection of autologous adiposetissue-derived mesenchymal stem cells (AD MSCs) in patientswith rotator cuff disease. The…
Read More Abstract A rotator cuff tear is an age-related common cause of pain and disability. Studies including our previously published ones have demonstrated that mesenchymal stem cells cultured under hypoxic conditions [hypoxic multipotent stromal cells (MSCs)] facilitate the retention of transplanted cells and promote wound healing. However, there are very few, if any, reports targeting the…
Read More Parkinson’s disease is a progressive neurodegenerative condition with a considerable health and economic burden1. It is characterized by the loss of midbrain dopaminergic neurons and a diminished response to symptomatic medical or surgical therapy as the disease progresses. Cell therapy aims to replenish lost dopaminergic neurons and their striatal projections by intrastriatal grafting. Here, we…
Read More Cell therapy is a potentially useful approach to treating heart failure (HF) secondary to chronic ischemic cardiomyopathy (ischemic HF). Despite controversy, the preclinical data in the field of cell therapy are clear: Although transplanted cells do not regenerate cardiomyocytes, preclinical studies have consistently shown that they improve cardiac performance. Bone marrow–derived mesenchymal stromal cells (MSCs)…
Read More Grabbing a coffee cup seems easy. But you need to be able to move your hand, stretch it out, and keep it steady. These movements are difficult for people with Parkinson’s disease. The disorder eats away at brain cells—called dopamine neurons—that control movement and emotion. Symptoms begin with tremors. Then muscles lock up. Eventually, the…
Read More Download the full article Chronic neuropathic pain is estimated to be on the rise, particularly with the expected increase in patients with diabetes within the US. Diabetic and nondiabetic patients were surveyed for sick days fromwork due to neuropathic pain; approximately two-thirds of these patients were found to consistently be taking days from work, and…
Read More ABSTRACT Mesenchymal stem cells (MSCs) are very attractive candidates in cell-based strategies that targetinflammatory diseases. Preclinical animal studies and many clinical trials have demonstrated thathuman MSCs can be safely administered and that they modify the inflammatory process in thetargeted injured tissue. Our laboratory developed a novel method that optimizes the anti-inflammatory effects of MSCs. We…
Read More Objective: Mesenchymal stem cells (MSCs) have been shown in animal models to attenuatechronic neuropathic pain. This preliminary study investigated if: i) injections of autologousMSCs can reduce human neuropathic pain and ii) evaluate the safety of the procedure. Methods: Ten subjects with symptoms of neuropathic trigeminal pain underwent liposuction.The lipoaspirate was digested with collagenase and washed…
Read More A nonphysiological repair of the lesioned nerve leading to the formation of neurinomas, altered nerveconduction, and spontaneous firing is considered the main cause of the events underlying neuropathicpain. It was investigated whether neural stem cell (NSCs) administration could lead to a physiologicalnerve repair, thus to a reduction of neuropathic pain symptoms such as hyperalgesia and…
Read More